Generalized Dystonia Following Imipramine Use in a Male Undergraduate: A Rare Phenomenon
Keywords:
Drug-induced movement disorders, Generalized dystonia, Imipramine, Rare adverse effectsAbstract
Imipramine, a tricyclic antidepressant, is commonly used for managing nocturnal enuresis in paediatric and adolescent populations. Although it is generally well-tolerated, rare adverse effects, including movement disorders, have occasionally been reported. Generalized dystonia, however, is an exceedingly rare and unexpected complication associated with imipramine.
References
1. Wilson PR, Thompson A, Ramirez L, Stewart M. Tricyclic antidepressants in pediatric practice: Efficacy and safety considerations. Pediatr Pharmacol J. 2020;34(3):150-60.
2. Johnson K, Clarke R. Management of nocturnal enuresis in adolescents. Pediatr Urol. 2018;45(2):89-94.
3. Brown DS, Patel A, Lin Y, Henderson CJ. Cardiovascular and neurological side effects of tricyclic antidepressants. J Clin Pharmacol. 2019;59(4):315-22.
4. Smith JA, Williams D, Roberts K, O'Connor P. Genetic predispositions in drug-induced movement disorders. Clin Genet. 2017;92(5):432-40.
5. Fahn S, Jankovic J, Hallett M. Dystonia: Diagnosis and Management. Mov Disord J. 2011;26(S3): S4-S23.
6. Rao SK, Mitra P, Banerjee R, Chandra S. Drug-induced movement disorders: Insights into mechanisms and management. Neurol Pharmacol. 2022;29(6):453-68.
7. Green MR, Taylor B, Cohen ML, Rodriguez E. Therapeutic approaches to dystonia: A clinical review. Neurol Ther. 2020;36(7):523-32.
8. Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions. Adv Psychiatr Treat. 2017;23(1):22-30.
9. Lin J, Liu W, Guan J, Cui J, Shi R, Wang L, Chen D, Liu Y. Latest updates on the serotonergic system in depression and anxiety. Synaptic Neurosci Front. 2023 May 9;15. doi:10.3389/fnsyn.2023.1124112
